Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2061 of 5804
-
Promising combo tackles tough cancers in early trial
Disease control CompletedThis research study is studying an investigational combination of drugs as a possible treatment for advanced solid tumors: melanoma, ovarian, renal, or colorectal cancer. The drugs involved in this study are: * Pembrolizumab * AMG386
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a common heart drug stop diabetes-related heart failure?
Disease control CompletedThis study will advance the investigator's knowledge of the integrated cardiorenal and humoral physiology in type 2 diabetic patients with and without pre-clinical diastolic dysfunction, and test a novel therapeutic strategy which may prevent a progression to symptomatic Stage C …
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New eye drops aim to soothe dry eye in bone marrow transplant patients
Symptom relief CompletedThe purpose of this Phase 1/2 study is to compare the safety and tolerability of four times a day (QID) dosing of a non-preserved topical ocular drop formulation of 10 vol/vol % and 30 vol/vol % of FD hPL to vehicle control eye drops in patients with Dry Eye Disease (DED) seconda…
Phase: PHASE1, PHASE2 • Sponsor: Cambium Bio Limited • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Hair loss breakthrough? study tests top treatments for CCCA
Disease control Recruiting nowThe objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a 14-Hour overnight fast help childhood cancer survivors?
Disease control OngoingThe purpose of this study is to test whether regularly not eating for at least 14 hours overnight ("intermittent fasting") is feasible and can improve blood sugar.
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New biopsy test could predict chemo success in breast cancer
Knowledge-focused OngoingThe current study aims to provide validation results of RNA Disruption Assay (RDA) as a tumour response assessment tool that uses tumour core biopsies taken starting from 35 +/- 4 days after the initiation of neoadjuvant chemotherapy.
Phase: NA • Sponsor: Rna Diagnostics Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Blood test may cut hospital stays for preeclampsia
Diagnosis CompletedThe aim of the PRECOG study is to determine in a prospective interventional randomized study whether the implementation of a predictive test based on the sFLT-1/PlGF ratio improves perinatal care and reduces costs, in patients with suspected preeclampsia before 35 weeks of gestat…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
New bone graft could improve spinal fusion outcomes
Disease control OngoingThe aim of this trial is to evaluate if P-15L bone graft (investigational device) is not inferior in effectiveness and safety to local autologous bone (and allograft where necessary) as an extender (control device) when applied in instrumented transforaminal lumbar interbody fusi…
Phase: NA • Sponsor: CeraPedics, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Ear zap device shows promise for teen nausea
Symptom relief CompletedThis study evaluates the efficacy of auricular neurostimulation via an non-invasive percutaneous electrical nerve field stimulator (PENFS) in adolescents with functional nausea. A neurostimulator is applied to the outer ear and stimulates several nerves that are thought to be inv…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Gentler vein harvesting may keep bypass grafts open longer
Disease control CompletedThe primary objective in this study is to investigate if vein grafts harvested and implanted with the non-touch technique are superior to conventional vein graft technique with respect to mid-term patency, in patients undergoing CABG surgery.
Phase: NA • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 26, 2026 15:26 UTC
-
New brain scan study seeks clues to Alzheimer's in diverse patients
Knowledge-focused Recruiting nowThe primary objective of this study is to measure the concentration and the regional brain distribution of pathologic amyloid deposition using the PET tracer \[C-11\]PiB in participants in the UAB Alzheimer's Disease Center cohort. Assessment of interactions between race and vasc…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Steering brain stimulation could ease Parkinson's symptoms
Symptom relief CompletedTwenty patients with idiopathic Parkinson's disease (PD) will be included into this single center randomized controlled double-blind clinical trial (RCT) in a cross-over design. The treatment consists of two different stimulation settings using (i) conventional omnidirectional st…
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Shock wave therapy shows promise for erectile dysfunction in new trial
Symptom relief CompletedObjective: To evaluate the efficacy and safety of radial shock waves for the treatment of erectile dysfunction \[ED\]. Patients and methods: Randomized, double-blind clinical trial. The study will include patients of legal age with diagnosis of ED and score on the International …
Phase: NA • Sponsor: Boston Medical Group • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Can two common drugs beat chemo nausea? large trial seeks answers
Symptom relief CompletedThis randomized phase III trial studies how well netupitant/palonosetron hydrochloride and dexamethasone with prochlorperazine or olanzapine work compared to netupitant/palonosetron hydrochloride and dexamethasone in improving chemotherapy-induced nausea and vomiting in patients …
Phase: PHASE3 • Sponsor: University of Rochester NCORP Research Base • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Proton beam therapy may offer gentler radiation for esophageal cancer
Symptom relief OngoingThe investigators plan to include both operable and inoperable patients with esophagus cancer in this prospective trial. Since both proton and photon treatments are biologically equivalent, the investigators do not expect a difference in tumor control compared to intensity modula…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
New surgical approach may improve outcomes for bowel disease patients
Disease control CompletedThis study compares the operative and functional outcomes of adding a transanal pathway to laparoscopic pelvic pouch surgery. The transanal pathway enables the surgeon to have better control when dividing the rectum and it may improve visualization in pelvic dissection. This coul…
Sponsor: Sahlgrenska University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New formula may help dialysis timing save lives
Knowledge-focused CompletedThe purpose of this study is to evaluate the impact of the optimal and late initiation of dialysis on the mortality and quality of life in end-stage renal disease (ESRD) patients by the Dialysis Initiation based on Fuzzy mathematics Equation (DIFE), which is a novel equation for …
Phase: NA • Sponsor: The First Affiliated Hospital of Dalian Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Heart attack study halted: could conditioning the heart and arm help?
Disease control TerminatedInfarct size is a major determinant of prognosis after AMI. Evidence indicates that the combination of intracoronary ischemic conditioning (ICIC) and remote ischemic conditioning (RIC) can significantly reduce infarct size in STEMI patients. Whether the combination of these two i…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Heart stent showdown: which imaging technique wins?
Knowledge-focused OngoingThe primary aim of this study is to compare the clinical efficacy and safety of OCT-guided(optical coherence tomography (OCT)-guided) and IVUS-guided(Intravascular ultrasound (IVUS)-guided) strategies in patients undergoing Percutaneous coronary intervention (PCI) with contempora…
Phase: NA • Sponsor: Seung-Jung Park • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New stent shows promise in unclogging heart arteries
Disease control OngoingIt is a randomized controlled trial to evaluate the safety and efficacy of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in comparison with the Medtronic Resolute Integrity™ Zotarolimus-Eluting coronary stent system in the treatment of subjects eligible f…
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC